South Korean Biotech Company Portrai Adopts Infortrend EonStor GS

Infortrend Technology, Inc. provided South Korean biotech company Portrai Inc. with EonStor GS enterprise unified storage solution to enable their research technology combining AI and RNA analysis for pharmaceutical drug development.

Portrai specializes in a RNA analysis technology called “Spatial Transcriptomics” to study novel targets and disease-related biomarkers. It uses the combination of AI and Spatial Transcriptomics aiming to change pharmaceutical drug development.

This analysis technology continuously generates data ranging from 10GB  to 1TB for an image sized 1cm², which requires storage space. Cloud storage solutions were hindered due to low Internet throughput and expensive monthly subscriptions for enterprise-grade plans. Thus, the company was looking for a reasonably priced on-site solution capable of storing and processing massive amounts of research data generated by AI computation. Other key priorities were data protection and easy data management.

Portrai chose Infortrend’s storage for its system stability and performance. To enable their advanced and demanding RNA analysis technology, the biotech company was advised to deploy EonStor GS 3024 unified storage and JBOD JB3060L, loaded with 84 NL-SAS drives of 18TB. This solution tackled the demand for storage by offering up to 1.2PB of available storage. Moreover, it features a redundant controller design to minimize downtime, data replication/mirroring for backup, future scalability for the growing research data, and efficient management with the browser-based user interface EonOne.

“In the course of pharmaceutical drug development, Spatial Transcriptomics and AI analysis generate massive amounts of data. Infortrend offers storage stability and capacity, combined with reasonable pricing, good customer service, and technical support, so we are extremely satisfied with Infortrend’s storage solution,” said Daeseung Lee, CEO, Portrai.